Literature DB >> 22564590

The role of CD14 and Toll-like receptor 4 of Kupffer cells in hepatic ischemia-reperfusion injury in rats.

X Luan1, Y Liu, M Li.   

Abstract

OBJECTIVE: The objective of this study was to study the role of CD14 and Toll-like receptor 4 (TLR4) in Kupffer cells (KCs) on ischemia reperfusion injury (IRI) in rat liver grafts.
METHODS: Isolated KCs were obtained from control, IRI, and IRI plus anti-CD14 antibody groups. We measured messenger RNA (mRNA) and protein expression of the lipopolysaccharide receptor CD14 and TLR4, nuclear factor kappa B (NF-κβ) activity, and TNF-α levels.
RESULTS: mRNA and protein expressions of CD14 and TLR4 were significantly higher in the IRI than in the control group, as were protein expressions of CD14 and TLR4 by flow cytometry and by Western blots. NF-κβ activity and tumor necrosis factor-α level in the IRI group were significantly higher than in the control group (3.17 ± 0.21 and 0.28 ± 0.03 vs 654.2 ± 3.6 pg/mL and 147.4 ± 1.1 pg/mL; t value = 4.11 and 4.29 for each; P < .01). Compared with the IRI group they were greatly decreased after anti-CD14 antibody treatment: 2.14 ± 0.17 vs 3.17 ± 0.21, 298.7 ± 1.8 pg/mL vs 654.2 ± 3.6 pg/mL (t value = 2.52 and 2.92 for each; P < .05). They were still significantly higher than the control group (t values of 3.01 and 3.27 for each; P < .01).
CONCLUSION: IRI up-regulated CD14 and TLR4 gene expression in KCs, and subsequently activated NF-κβ to produce cytokines.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564590     DOI: 10.1016/j.transproceed.2011.11.001

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  CD14 contributes to warm hepatic ischemia-reperfusion injury in mice.

Authors:  Changchun Cai; Xiaolian Shi; Sebastian Korff; Jinxiang Zhang; Patricia A Loughran; Xiangcai Ruan; Yong Zhang; Li Liu; Timothy R Billiar
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

Review 2.  Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments.

Authors:  Fengqiang Gao; Xun Qiu; Kai Wang; Chuxiao Shao; Wenjian Jin; Zhen Zhang; Xiao Xu
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

3.  miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6.

Authors:  Weiwei Jiang; Liangliang Kong; Qingfeng Ni; Yeting Lu; Wenzhou Ding; Guoqing Liu; Liyong Pu; Weibing Tang; Lianbao Kong
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  The impact on the bioenergetic status and oxidative-mediated tissue injury of a combined protocol of hypothermic and normothermic machine perfusion using an acellular haemoglobin-based oxygen carrier: The cold-to-warm machine perfusion of the liver.

Authors:  Yuri L Boteon; Richard W Laing; Andrea Schlegel; Lorraine Wallace; Amanda Smith; Joseph Attard; Ricky H Bhogal; Gary Reynolds; M Thamara PR Perera; Paolo Muiesan; Darius F Mirza; Hynek Mergental; Simon C Afford
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

5.  Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.

Authors:  Yuji Ogawa; Kento Imajo; Masato Yoneda; Takaomi Kessoku; Wataru Tomeno; Yoshiyasu Shinohara; Shingo Kato; Hironori Mawatari; Yuichi Nozaki; Koji Fujita; Hiroyuki Kirikoshi; Shin Maeda; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.